Browsing: GLP1

Below is an approximation of this video’s audio content. To see any graphs, charts, graphics, images, and quotes to which…

Preventive health offering combines ‘microdosed’ GLP-1 meds with biomarker monitoring and behavior change guidance. Digital health platform Noom is broadening…

Credit: CIPhotos / iStock / Getty Images Plus An analysis of nearly 50 randomized controlled trials has found no link…

Credit: selvanegra/ Getty Images Research led by National Cheng Kung University, Taiwan, suggests glucagon-like peptide 1 (GLP-1) receptor agonists can…

The WHO warns that the current production levels of GLP-1 therapies are insufficient to equitably provide care for the billion…

November’s highlights include a spike in global debates over ultra-processed foods (UPFs), US nutrition assistance, Nestlé’s dismissal of added sugar…

Long shot Phase 3 trial finds semaglutide did not deliver a statistically significant reduction in Alzheimer’s progression. Pharma giant Novo…

Credit: Juan Gaertner/Science Photo Library/Getty Images The results from two Phase III trials announced this week show Novo Nordisk’s GLP-1…

GLP-1 drugs have dramatic effects on weight loss but are often accompanied by unwanted side effects. A better understanding of…

In addition to treating diabetes and obesity, GLP-1 drugs like Ozempic and Wegovy also appear to help with a range…